ReviewCureus2026

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers for Cardiovascular and Renal Protection in Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Ayman Alqurain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.